Next Gen Digital Diagnostic Platform to Detect Multiple Pathogens within 5 Minutes at Gene Level
|
By HospiMedica International staff writers Posted on 30 Jun 2023 |

An advanced digital diagnostic platform with the capability to detect multiple pathogens in five minutes at the molecular gene level and priced significantly lower than current molecular tests is all set to disrupt the PCR market.
Check4 by IdentifySensors Biologics (Cleveland, OH, USA) is a next-generation digital diagnostic platform that has been developed to detect the genetic material of a wide range of pathogens for over-the-counter and point-of-care use. The Check4 testing platform comprises two components: a reusable Bluetooth reader roughly the size of a mobile phone, and disposable test cartridges that connect to the reader. Each test sample can simultaneously detect up to three different pathogens. Digital graphene sensors within the cartridges target conserved regions of the genome, thereby ensuring high sensitivity and specificity without the need for enzymatic amplification or reagents.
The sensors in the disposable cartridges can be customized to identify a broad range of pathogens that display similar symptoms. Multiplex tests are in development for respiratory pathogens (COVID, RSV, and influenza), gastrointestinal pathogens (Norovirus, Rotavirus, and Adenovirus), and sexually transmitted pathogens (HIV, Hepatitis, Chlamydia, Gonorrhea, and Herpes). Other tests under development include those for SEPSIS, MRSA, Lyme disease, and tropical pathogens such as Zika, Dengue, Yellow Fever, and West Nile virus. Previous research indicates that Check4 can potentially diagnose infections like COVID, RSV, and influenza even before patients exhibit symptoms. IdentifySensors has commenced testing this novel diagnostic device in anticipation of FDA submissions. Clinical studies for the Check4 diagnostic device are slated for this year as part of an extensive testing platform designed to be adapted for detecting a broad range of additional pathogens in the coming years.
"In preliminary studies we have seen encouraging results of this new technology," said Greg Hummer M.D., IdentifySensors co-founder and CEO. "We are excited to test these devices and move forward with additional targets that detect a wide range of infections."
Related Links:
IdentifySensors Biologics
Latest Point of Care News
- Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
- Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
- Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
- Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
- New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
- Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
- AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
- Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
- Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
- Portable MRI System Accelerates Emergency Brain Imaging and Triage
- Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
- Portable MRI System Gains CE Mark for Point-of-Care Brain Imaging
Channels
Artificial Intelligence
view channel
AI Tool Improves Smartphone Detection of Abnormal Pediatric Lung Sounds
Respiratory disease in children remains a major clinical concern worldwide. Abnormal lung sounds can indicate pediatric respiratory illness, but standard auscultation usually requires an in-person examination... Read more
AI Tool Detects Coronary Heart Disease from Face and Tongue Images
Coronary heart disease (CHD) develops when fatty plaques narrow the arteries supplying the heart muscle, restricting blood flow and sometimes first presenting as chest pain, myocardial infarction, or another... Read moreCritical Care
view channel
Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk
On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more
Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant
Donor hearts remain extremely scarce in the U.S. transplant system, with one in five candidates dying or being removed from the waiting list before receiving an organ. Current allocation rules may also... Read moreSurgical Techniques
view channel
New Ultrasonic Surgical Platform Adds Control for Bone and Soft Tissue Removal
Surgical removal of bone and soft tissue requires controlled resection with sufficient power and precision. In demanding neurosurgical procedures, workflow efficiency, ergonomics, and system integration... Read more
New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation
When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy
Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more
MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease
Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read moreBusiness
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more







